Obese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and …
L Karatisidis, K Zagoridis, T Mprotsis, C Misidou… - Thrombosis …, 2024 - Elsevier
Introduction Recommendations about proper anticoagulation in obese patients, body mass
index (BMI)> 30 kg/m2, are not yet clearly defined. Obese patients were included in …
index (BMI)> 30 kg/m2, are not yet clearly defined. Obese patients were included in …
Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study
C Escobar, B Palacios, M Villarreal, M Gutiérrez… - Journal of Clinical …, 2024 - mdpi.com
Objective. To analyze the clinical characteristics of patients taking Factor Xa inhibitors
(FXai), either direct FXai or enoxaparin (only in active cancer patients), and to estimate the …
(FXai), either direct FXai or enoxaparin (only in active cancer patients), and to estimate the …
International Normalized Ratio Predicts Recurrence and Bleeding in Patients With Acute Venous Thromboembolism Who Undergo Direct Oral Anticoagulants
Y Zhao, Y Cheng, Y Luo, Q Yao, J Qu… - Clinical and Applied …, 2024 - journals.sagepub.com
Prothrombin time/international normalized ratio (PT/INR) is related to both antithrombotic
effect and risk of bleeding. Its role in the prediction of venous thromboembolism (VTE) …
effect and risk of bleeding. Its role in the prediction of venous thromboembolism (VTE) …
The Influence of High Body Mass Index (BMI > 35 kg/m2) on Apixaban Plasma Concentration in Patients with Atrial Fibrillation
M Hilu, M Issawy, R Colodner, H Eitam… - American Journal of …, 2024 - Springer
Purpose Apixaban, a direct oral anticoagulant is administered for stroke prevention in atrial
fibrillation patients. Dosing adjustment is guided by renal function, age, and body weight …
fibrillation patients. Dosing adjustment is guided by renal function, age, and body weight …